Elevated Level of Plasma C-reactive Protein in Patients with Unstable Angina: Its Relations with Coronary Stenosis and Lipid Profile

Abstract

C-reactive protein (CRP) is a sensitive marker of inflammation, and elevated levels have been associated with future risk of cardiovascular events. To explore the role and relationship of CRP and coronary stenosis in the development of unstable angina (UA), plasma levels of CRP were determined on admission in 45 patients with UA, and in 42 patients with stable angina (SA) using high-sensitivity ELISA. Coronary angiography was performed in all patients with coronary heart disease (CHD), and severity of coronary stenosis was evaluated by a quanti tative analysis. Lipid measurement was performed using automatic biochemical analyzer. Data available from patients with CHD were compared with those of 41 control subjects. The results showed that plasma levels of CRP are significantly higher in patients with UA than those in patients with SA and control subjects (5.1 ± 1.4 mg/L vs 1.7 ±0.4 mg/L and 1.3 ±0.2 mg/L, p < 0.01, respectively) with no difference between the latter two groups (p > 0.05); the total incidence of clinical events during in-hospital follow-up was higher in the group A (p < 0.01 ); the scores of coronary stenosis are significantly higher in patients with SA than those in patients with UA (4.9 ±2.1 vs 3.4 ± 1.4, p < 0.05); there is no correlation between plasma levels of CRP and serum total cholesterol (TC) as well as high-density lipoprotein cholesterol (HDL-C) in both groups (p > 0.05 respectively); there was no correlation between plasma levels of CRP and severity of coronary stenosis was found in patients with UA (p > 0.05) but a significant positive association in patients with SA (p < 0.00 1 ); and the patients with persistent, severe, treatment-unresponsive UA had significantly higher CRP levels as well as incidence of clinical events than patients with treatment-responsive UA (7.4 ± 1.8 mg/L vs 2.6 ± 1.3 mg/L, p < 0.01; 0 vs 22.2%, p < 0.05). The present data suggested that inflammation may play an important role in the pathogenesis of UA, and the plasma levels of CRP might have a higher prognostic value than the severity of coronary stenosis correlated with the clinical outcome of insta bility despite of lipid profile status.

Get full access to this article

View all access options for this article.

References

Ridker PM , Glynn RJ , Henneken CH : C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation 97:2007-2011, 1998.

Sato T. , Takebayashi S. , Kohehi K. : Increased subendothelial infiltration of the coronary arteries with monocytes/macrophages in patients with unstable angina. Atherosclerosis 68:191-197, 1995.

Mazzone A. , De Servi S. , Ricevuti G. , et al: Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 88:358-363, 1993.

Libby P. : Molecular bases of the acute coronary syndromes. Circulation 91:2844-2850, 1995.

Li J-J. , Li G. - S: The relationship between C-reactive protein and coronary heart disease . Chin J Circ 14: 319-321, 1999.

Liuzzo G. , Biasucci LM , Gallimore JR , et al: The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331:417-424, 1994.

Erren M. , Reinecke H. , Junker R. , et al: Systemic inflammatory parameters in patients with atherosclerosis of the coronary and peripheral arteries. Arterioscler Thromb Vasc Biol 19: 2355-2363, 1999.

Rifai N. , Joubran R. , Yu H. , et al: Inflammatory marker in men with angiographic documented coronary heart disease. Clin Chem 45: 1967-1973, 1999 .

Gensini GG : A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 51:606-610, 1983.

10.

Ridker PM , Cushman M. , Stampfer MJ , et al: Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 97:425-428, 1998.

11.

Ridker PM , Burning JE , Shih J. , et al: Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98:731-733, 1998.

12.

Haverkate F. , Thompson SG , Pyke SD , et al: Production of C-reactive protein and risk of coronary events in stable and unstable angina: European concerted action on thrombosis and disabilities angina pectoris study group. Lancet 349:462-466, 1997.

13.

Morrow DA , Rifai N. , Antman EM , et al: C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: A TIMI 11A substudy. J Am Coll Cardiol 31:1460-1465, 1998.

14.

Tracy RP : Inflammation in cardiovascular disease: Cart, house, or both? Circulation 97: 2000-2002, 1998 .

15.

Torzewski J. , Torzewski M. , Boeyer DE , et al: C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries. Arterioscler Thromb Vasc Biol 18:1393-1399, 1998 .

16.

Caligiuri G. , Liuzzo G. , Biasucci ML , et al: Immune system activation follows inflammation in unstable angina : Pathogenetic implication . J Am Coll Cardiol 32:1295-1304, 1998 .

17.

Vlaicu R. , Rus HG , Niculescu F. , et al: Immunoglobulins and complement components in human aortic atherosclerotic intima. Atherosclerosis 55 :35-50, 1985.

18.

Reynolds GD , Vance RP : C-reactive protein immunohistochemical localization in normal and atherosclerotic human aortas. Arch Pathol Lab Med 111:265-269, 1987.